PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Leaf and root extracts demonstrated antiplasmodial potentials in mice models, with effects being dosage and duration-dependent [PMID:34394229, PMID:34659429].
Butanol fraction of leaves reduced blood glucose levels, enhanced oral glucose tolerance, and restored insulin secretion in diabetic rats [PMID:33840309]. Stem bark aqueous extract also normalized blood glucose in diabetic mice [PMID:40999897].
Aqueous fraction of leaves suppressed carrageenan- and formaldehyde-induced rat paw edema [PMID:27974282].
Aqueous stem bark extract exhibited anticataract activity in Sprague Dawley rat models of diabetic and age-related cataracts [PMID:37560323].
Aqueous and methanol stem-bark extracts were assessed for anticolitis effects in DSS-induced intestinal colitis models [PMID:32565862].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37894548 (2023) — Antispasmodic Effect of Alstonia boonei De Wild. and Its Constituents: Ex Vivo and In Silico Approaches. · Molecules (Basel, Switzerland)
- 2.PMID: 36323654 (2023) — In vitro effects of 2-methyl-3-propylbutane-1,4-diol purified from Alstonia boonei on erythrocyte membrane stabilization and mitochondrial membrane permeabilization. · Chemical biology & drug design
- 3.PMID: 36965546 (2023) — Neuroprotection by Alstonia boonei De Wild., Anacardium occidentale L., Azadirachta indica A.Juss. and Mangifera indica L. · Journal of ethnopharmacology
- 4.PMID: 37864233 (2023) — Phytochemical analysis, in vitro and in silico effects from Alstonia boonei De Wild stem bark on selected digestive enzymes and adipogenesis in 3T3-L1 preadipocytes. · BMC complementary medicine and therapies
- 5.PMID: 37560323